Post-IPO Debt - Dicerna Pharmaceuticals
Investment Firm
Overview
Dicerna Pharmaceuticals is a biotechnology company with a focus on the development of innovative treatments for rare inherited diseases.
Announced Date
Mar 30, 2017
Funding Type
Post Ipo Debt
Highlights
Location
United States, North America
Social
Participant Investors
6
Round Details and Background
Dicerna Pharmaceuticals raised $70000000 on 2017-03-30 in Post-IPO Debt
Dicerna Pharmaceuticals is a biotechnology company with a focus on the development of innovative treatments for rare inherited diseases.
Company Funding History
8
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Jul 15, 2008 |  Series A - Dicerna Pharmaceuticals | 3 | - | 8.4M |
| Aug 05, 2010 | Series B - Dicerna Pharmaceuticals | - | 29.1M | |
| Jul 31, 2013 | Series C - Dicerna Pharmaceuticals | 9 | - | 60.0M |
| Oct 21, 2010 | Series B - Dicerna Pharmaceuticals | 2 | - | 4.0M |
Recent Activity
There is no recent news or activity for this profile.